Entero Healthcare Solutions Ltd
Incorporated in 2018, Entero Healthcare
Solutions Ltd is in the business of distribution
and marketing of pharmaceutical and surgical products and allied services[1]
- Market Cap ₹ 5,754 Cr.
- Current Price ₹ 1,323
- High / Low ₹ 1,584 / 991
- Stock P/E 63.9
- Book Value ₹ 387
- Dividend Yield 0.00 %
- ROCE 6.71 %
- ROE 4.98 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Stock is trading at 3.42 times its book value
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Retail Industry: Trading
Part of BSE Allcap BSE Consumer Discretionary Nifty Microcap 250 Nifty Total Market BSE IPO
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|
| 1,350 | 1,773 | 2,522 | 3,300 | 3,922 | 4,791 | |
| 1,326 | 1,758 | 2,498 | 3,236 | 3,810 | 4,639 | |
| Operating Profit | 23 | 15 | 24 | 64 | 112 | 152 |
| OPM % | 2% | 1% | 1% | 2% | 3% | 3% |
| 5 | 11 | 4 | 6 | 14 | 41 | |
| Interest | 13 | 20 | 29 | 49 | 66 | 48 |
| Depreciation | 12 | 16 | 20 | 24 | 25 | 29 |
| Profit before tax | 4 | -11 | -20 | -4 | 36 | 115 |
| Tax % | 67% | 42% | 49% | 201% | -12% | |
| 1 | -15 | -29 | -11 | 40 | 97 | |
| EPS in Rs | 93.81 | -1,550.90 | -77.71 | -28.12 | 8.99 | 20.72 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 30% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 66% |
| TTM: | 524% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 15% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 4 | 4 | 43 | 43 |
| Reserves | -16 | -32 | -62 | -73 | 1,595 | 1,639 |
| 603 | 720 | 974 | 1,101 | 338 | 361 | |
| 162 | 147 | 210 | 275 | 369 | 609 | |
| Total Liabilities | 749 | 836 | 1,125 | 1,308 | 2,345 | 2,653 |
| 186 | 189 | 262 | 268 | 289 | 554 | |
| CWIP | 2 | 2 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 3 |
| 560 | 645 | 863 | 1,040 | 2,056 | 2,096 | |
| Total Assets | 749 | 836 | 1,125 | 1,308 | 2,345 | 2,653 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| -37 | -69 | -35 | -45 | -37 | |
| -203 | -31 | -162 | -49 | -704 | |
| 217 | 89 | 211 | 73 | 863 | |
| Net Cash Flow | -23 | -11 | 14 | -21 | 122 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 63 | 50 | 54 | 57 | 57 |
| Inventory Days | 57 | 54 | 49 | 41 | 43 |
| Days Payable | 32 | 22 | 22 | 25 | 24 |
| Cash Conversion Cycle | 88 | 82 | 81 | 73 | 77 |
| Working Capital Days | 88 | 85 | 79 | 72 | 71 |
| ROCE % | 1% | 1% | 5% | 7% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - Certificate under Regulation 74(5) for Q1 2025.
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
28 Mar - Acquired balance equity shares in Getwell, now wholly owned.
-
Closure of Trading Window
24 Mar - Closure of trading window effective April 01, 2025.
-
Announcement under Regulation 30 (LODR)-Change in Management
21 Mar - Resignation of CFO and appointment of new CFO.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On March 21, 2025
21 Mar - Resignation of CFO and appointment of new CFO.
Concalls
-
Feb 2025TranscriptPPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT REC
-
May 2024TranscriptNotesPPT
-
Mar 2024Transcript PPT
Business Overview:[1]
EHSL, a leading Healthcare Supply Chain Solutions Specialist, ranks among India’s top three healthcare product distributors by revenue, offering demand fulfillment and generation solutions to manufacturers.